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Mild traumatic brain injury (mTBI) is one of the most common neuronal insults and
can lead to long-term disabilities. mTBI occurs when the head is exposed to a rapid
acceleration-deceleration movement triggering axonal injuries. Our limited understanding
of the underlying pathological changes makes it difficult to predict the outcome of mTBI.
In this study we used a scalable rat model for rotational acceleration TBI, previously char-
acterized for the threshold of axonal pathology. We have analyzed whether aTBI just above
the defined threshold would induce any detectable behavioral changes and/or changes in
serum biomarkers. The effect of injury on sensory motor functions, memory and anxiety
were assessed by beam walking, radial arms maze and elevated plus maze at 3–7 days fol-
lowing TBI. The only behavioral deficits found were transient impairments in working and
reference memory. Blood serum was analyzed at 1, 3, and 14 days after injury for changes
in selected protein biomarkers. Serum levels of neurofilament heavy chain andTau, as well
as S100B and myelin basic protein showed significant increases in the injured animals at
all time points. No signs of macroscopic injuries such as intracerebral hematomas or con-
tusions were found. Amyloid precursor protein immunostaining indicated axonal injuries
at all time points analyzed. In summary, this model mimics some of the key symptoms of
mTBI, such as transient memory impairment, which is paralleled by an increase in serum
biomarkers. Our findings suggest that serum biomarkers may be used to detect mTBI.The
model provides a suitable foundation for further investigation of the underlying pathology
of mTBI.
Keywords:mild traumatic brain injury, brain traumamodel, DAI, serum biomarker, behavioral outcome,APP, S100B,
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INTRODUCTION
Mild or minor traumatic brain injury (mTBI) is one of the most
common neurological disorders and it is estimated to comprise
70–90% of all traumatic brain injuries (Bazarian et al., 1999).
Most patients recover well, however long-term problems such as
headaches, vertigo, nausea, sleep disorders, depression, poor con-
centration, and memory problems are common (Middleboe et al.,
1992; Watson et al., 1995). The mTBI patients have a brief period of
unconsciousness, but the usual findings at admission to a hospital
is Glasgow Coma Scale values of 13–15 and Computer tomogra-
phy (CT) indicates no detectable injuries (Bazarian et al., 2006).
The serum biomarker S100B has been suggested as an additional
screening tool to differentiate between mTBI and more severe
forms of TBI (Kovesdi et al., 2010; Unden and Romner, 2010).
Currently, the understanding of mTBI and how it is diagnosed
is poor. It is possible that there are a number of TBI subtypes
that are categorized as mTBI. Such heterogeneity among injuries
may account for the documented differences in recovery following
mTBI. It is possible that the injuries resulting from some of the
potential mTBI subclasses currently are not recognized in clinical
practice. Because mTBI is a non-fatal injury there are few avail-
able neuropathology data from humans. There are two existing
studies where the brain tissue of patients who suffered from mTBI
but who subsequently died from other causes has been investi-
gated histologically (Blumbergs et al., 1994, 1995). In both studies
axonal damage was demonstrated by amyloid precursor protein
(APP) staining, indicating the importance of this pathology in
mTBI. Advanced neuroimaging techniques such as diffusion ten-
sor imaging (DTI) have been used to investigate structural changes
in patients with mTBI and have showed the presence of axonal
injuries (Niogi et al., 2008a,b; Wilde et al., 2008; Chu et al., 2010;
Mayer et al., 2010).
One of the reasons why we currently understand so little about
mTBI is the lack of high fidelity, scalable models. The translation
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between experiments on deeply anesthetized animals and a con-
dition, which in the clinical situation is recognized by a brief
unconsciousness or occurrence of symptoms such as headache,
alone is challenging. It is believed that mTBI occur when the head
is exposed to loads that produce high acceleration-deceleration
of the brain tissue, which in combination with its inertia induces
forces in the tissue and results in diffuse injuries. One of the most
frequently used models for a graded impact acceleration injury
is the Marmarou’s weight drop (Marmarou et al., 1994). How-
ever, when using this model, even impact acceleration of mild
severity produces hemorrhages (Folkerts et al., 1998) and concerns
have been raised regarding lack of control over the precise condi-
tions of impact (Cernak, 2005; Morales et al., 2005). Cernak et al.
(2004) developed a model very similar to that of Marmarou with
improved control and reproducibility of the impact to the head.
Maruichi et al. (2009) constructed a model based on the method-
ology introduced by Cernak but with advanced ability to grade the
impact. However subarachnoid and intraventricular hemorrhages
in addition to hemorrhages in corpus callosum were frequently
observed even at mild severity.
We have recently described a model for graded acceleration-
deceleration induced TBI. We were able to identify a threshold
value at which there is dispersed axonal pathology with a distribu-
tion similar to clinical diffuse axonal injuries (DAI), i.e., in the cor-
pus callosum, but without any detectable bleeding (Davidsson and
Risling, 2011; Risling et al., 2011). This acceleration-deceleration
injury also results in gene expression changes in the hippocampus
and an increase in serum levels of S100B. In the present study we
have analyzed whether this injury results in behavioral changes or
increase in serum levels of biomarkers indicative of axonal injury.
MATERIALS AND METHODS
EXPERIMENTAL TRAUMATIC BRAIN INJURY
Adult Sprague-Dawley male rats (287–474 g, n= 75) were used.
We choose relatively larger animals since our experiments have
shown better stability of the skull bone in larger animals, higher
survival rate, and good repeatability. The animals were deeply
anesthetized by an intra-abdominal injection of a 2.4 ml/kg mix-
ture of 1 ml Dormicum® (5 mg/ml Midazolam, Roche), 1 ml
Hypnorm® (Janssen) and 2 ml distilled water. Thereafter, the ani-
mals were given 0.2 ml/kg intra-muscular injections of the above
mentioned mixture every 0.5 h until trauma and surgery was
completed. A midline incision was made through the skin and
periosteum on the skull vault, and parts of the frontal, nose, and
parietal bones were freed from adherent tissue. The exposed bone
was then treated with weak phosphoric acid, dried, and gently
sanded prior to the fixation of a curved aluminum plate, which
was shaped to match the contour of the exposed skull. The plate
was attached to the bone using dental glue. Then the attachment
plate was inserted and secured to a rotating bar that enabled
rotation of the head in the sagittal plane. During the trauma,
a solid brass weight impacted the rotating bar and the impulse
produced subjected the animal heads to a short lasting sagittal
plane rearward rotational acceleration, mean± SD of the peak
value were 1.5± 0.1 Mrad/s2, for about 0.4 ms. The sham injured
control animals received identical anesthesia and surgical prepara-
tion as described above but without the trauma to the head. This
trauma model has been described in detail previously (Davids-
son and Risling, 2011). A schematic representation of the model
for rotational TBI is presented in Figure 1. The work was per-
formed in accordance with the Swedish National Guidelines for
animal experiments, and was approved by the Animal Care and
Use Ethics Committee in Stockholm.
BEHAVIORAL TESTING
In the present study, we investigated the functional outcome in 11
sham operated and 12 injured animals. We used well-established
models of sensory motor function (beam walking test), memory
(radial arm maze; RAM), and anxiety (elevated plus maze; EPM)
that have previously been used in a penetrating TBI model in our
laboratory (Plantman et al., 2012).
BEAMWALKING TEST
Fine motor coordination was assessed by using a beam walking
test. This test essentially examines the ability of the animal to
remain upright and to walk on an elevated and relatively narrow
beam (Goldstein and Davis, 1990). The setup consisted of a rigid
2.5 cm wide flat beam of 1.5 m in length leading to a brightly deco-
rated goal-box. The beam was placed at 50 cm above the floor and
foam cushions were placed underneath the beam. 3 days before
habituation, animals were deprived of food until their body weight
was reduced to 85% of the initial free-feeding weight (approx.
3 days). In the habituation phase (2 days) the rat was first placed
into the goal-box to feed on the reward pellets provided (45 mg,
Raspberry flavored, Testdiet, UK). Subsequently, progressive beam
training was initiated, starting from the beam-end closest to the
goal-box and progressing gradually to the opposite end. At testing,
the time taken for the animals to cross the 1 m length of the beam
was recorded with a stopwatch. Animals were finally tested 1 day
prior to surgery. Thereafter testing was performed at 3–7 days post
surgery. Animals that were unable to perform the test were desig-
nated “Immobile,” and no time was entered. However, the animals
were kept and re-assessed at each testing interval.
ELEVATED PLUS MAZE
Elevated plus maze relies on the animal’s preference for dark and
enclosed spaces over bright, exposed areas. It involves a conflict
between the desire to explore and the anxiety of exposure and
height (Lau et al., 2008). The EPM has a centrally placed open
platform (height above floor: 50 cm) from which four 30 cm long
arms extend, two open (i.e., without walls) and two closed (i.e.,
with 30 cm high walls; Walf and Frye, 2007). The experimental
procedure was initiated by the placement of the rat on the cen-
tral platform with its head facing a closed arm. The rat was then
allowed to roam the maze without any visual or audio distractions
for 5 min. The whole EPM exposure was video-recorded, and var-
ious behavioral patterns were subsequently counted and timed.
This included the following, (1) time spent in open arms, (2) time
spent in closed arms, (3) number of rearings, and (4) number of
central platform crossings. The rats were tested on the EPM at
3 days post injury.
RADIAL ARMMAZE
To measure working and reference memory, we used the RAM. The
maze (Panlab, Spain) consisted of an octagonal central platform
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FIGURE 1 | Schematic representation of the model for rotational
TBI. In Figure (A), the relation between the accelerator (modified air
gun) and the head holder is represented. The attachment plate for the
rat head is shown in (B). A metallic level, which extends to the top of
the test rig, is mounted on this attachment plate. (C–E) is a graphic
representation of a schematic sequence which shows how the striker
projectile hits the level in (D), which results in the backward rotation
in (E).
with eight automated sliding guillotine doors giving access to eight
radiating arms of equal lengths (measurements of the maze is as
follows: width, 1690 mm; length, 1250 mm; and height, 1450 mm).
Each arm contains two pairs of photoelectrical cells mounted on
the proximal and distal ends of the arm to differentiate between
arm entries and visits. In addition, a food site is located at the end
of each arm. The contents of the food sites are not visible from the
central platform. Prominent extra-maze visual cues are present
to allow spatial recognition of arm position. During habituation
phase (2–3 days) the food-restricted rats were familiarized with the
maze. All doors were open and food rewards were scattered around
the maze to entice the rats to explore. After the rats were allowed
to freely explore the maze and had consumed the food rewards at
the food disk at the distal arm, the training phase started (span
of 10 or more days). To measure reference memory, the rats were
trained to retrieve four food pellets from each selected baited arm
only once. To train the rats to do so, they were first placed in the
center arena with all doors closed. After 5 s, all eight doors to the
radial arms were opened and the rats were allowed to explore the
RAM until the entrance into one arm was detected. Then all doors
closed, except to the arm being visited. After the animal returned
to the central area, the open door would close. This was followed
by a confinement time (5 s) and then the doors reopened for a
new round of choice. This cycle was repeated automatically until
the rats visited all four baited arms or after 10 min had elapsed.
For each trial, the arm choice, latency to obtain all the pellets (i.e.,
response latency), and the number of visits to each arm was auto-
matically recorded by the MazeSoft software (Panlab, Spain). After
each run, the maze was cleaned with absorbing paper to prevent
a bias due to olfactory cues. Over time, the rats would also learn
that certain arms were not baited and avoid them accordingly.
Animals were trained twice each day until a stable baseline perfor-
mance (>75% accuracy) was reached. After surgery and exposure
to trauma or sham exposure, rats were tested daily, starting at 72 h
post injury, up to 7 days.
REVERSE PHASE PROTEIN MICROARRAY
A total of 24 animals were used for RPPM analysis, nine exposed
and nine sham operated controls equally distributed on different
surviving time 1 day (n= 3), 3 days (n= 3), 14 days (n= 3). In
addition six normal controls were included.
The animals were deeply sedated by a 2.4 ml/kg intra-
abdominal injection of a mixture of 1 ml Dormicum® (5 mg/ml
Midazolan, Roche), 1 ml Hypnorm® (Janssen), and 2 ml of dis-
tilled water and sacrificed through vast drainage of peripheral
blood. The blood was drained and centrifuged and serum was
collected, aliquoted, and frozen on dry ice for proteomic analysis.
The primary antibodies used were for neurofilament heavy chain
(NF-H; 1:20, Sigma), the microtubule associated protein total-Tau
(1:20, Santa Cruz), S100B (1:20, Abcam), and myelin basic protein
(MBP; 1:20, Santa Cruz). The detailed method of proteomics has
been previously described (Gyorgy et al., 2010).
IMMUNOHISTOCHEMISTRY
A total of 28 animals were used for immunohistochemistry. Four
injured and four sham operated controls were analyzed at 1-, 3-,
and 5 days and two injured and two sham operated animals were
used at 7 days.
The mid region of frozen brain tissue was cut by Cryo-Star HM
560 M (MICROM International GmbH) in coronal sections with
a thickness of 14µm and placed on Superfrost Plus slides. They
were subsequently incubated in a humid chamber at 4˚C for 24 h
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with either a rabbit polyclonal antibody against beta APP (β-APP;
Zymed, dilution 1:100). Primary antibodies were diluted in a solu-
tion of 0.3% Triton, 5% bovine serum albumin, and 0.1% sodium
azide in 0.01 M PBS. Donkey serum (5%) was added to minimize
background staining. A Cy2-conjugated donkey anti-rabbit IgG
(Jackson Immuno-Research, Inc., dilution 1:100) was used. The
secondary antibodies were preabsorbed against the tissue as spec-
ified by the manufacturer. After the sections were rinsed in PBS,
they were mounted in a mixture of glycerol and PBS (1:2) and
cover slipped.
Sections were examined in a Nikon E600 microscope (Nikon,
Shinjuku, Japan) using appropriate filter settings or a confocal
C1 unit. Images were captured with a Nikon Digital Sight DS-
U1 (5 megapixel) camera, controlled with Nikon NIS Elements
software.
STATISTICAL ANALYSIS
The percent increase of each biomarker in sham and injured ani-
mals compared to normal controls were analyzed. These values
were used in a two-way analysis of variances (ANOVA) with
Time (1-, 3-, and 14 days) as a within-subject factor and Group
(sham, injured) as a between-subjects factor. For behavioral analy-
sis a one-way analysis of variances (ANOVA) was performed
with Group (sham, injured) as a between-subjects factor. All the
ANOVA analysis was followed up by pairwise comparison based on
estimated marginal means and Bonferroni correction was included
in all analyzes. All statistical analyses were carried out using SPSS
20.0 with an alpha level set to p< 0.05 (two-tailed).
RESULTS
BEHAVIORAL CHANGES
All animals survived the trauma and were behaviorally tested with
beginning at 3 days following injury.
BEAMWALK
Fine motor coordination was assessed by using a beam walking
test. All the animals were able to remain upright and to walk on
the beam at the initial trial following injury. All the animals con-
tinued to complete the test at all the following time points up to
7 days and no significant differences could be detected between the
injured and the sham animals.
ELEVATED PLUS MAZE
Elevated plus maze relies on the animal’s preference for dark and
enclosed space over bright and exposed areas and involves a con-
flict between the desire to explore and the anxiety of exposure
and height. The animals were tested at day 3 following injury and
no significant differences were found between the shams and the
injured group in time spent in closed or open arms or at the center
platform (Figure 2A). Nor did we observe any significant changes
in the number of total arm entries, rearing activity, or the number
of crossings (Figure 2B). In conclusion, these results indicate that
the animals did not experience an increase in anxiety.
RADIAL ARMMAZE
The working and reference memory was assed by RAM from day
3 up to day 7 following injury. There was a limited but statis-
tically significant increase in working memory errors at day 3
(F1,126= 5.9, p= 0.016) and reference memory errors at day 5
(F1,126= 5.5, p= 0.021) in injured animals compared to sham
as illustrated in Figures 3A,B, respectively. No changes could be
detected in visit response latency (time taken to correctly find all
four baited arms) or the number of visits in the bated arms or all
arms, at any time point following injury (Figures 3C,D).
CHANGES IN SERUM BIOMARKER LEVELS
The result of RPPM values obtained in log 10 values for nor-
mal controls, sham and injured animals are given in Table 1.
The percentage increase of each biomarker in both sham
and injured animals compared to normal controls are illus-
trated in Figure 4. There was a significant difference between
the sham and injured animals in all the biomarkers; S100B
(F1,16= 24.3, p=<0.001), MBP (F1,16= 57.7, p=< 0.001), NF-
H (F1,16= 19.3,p=< 0.001), and Tau (F1,16= 27.5,p=< 0.001).
The most pronounced increase was found in Tau at all time
points (Figure 4). The temporal changes were significant in MBP
(p= 0.022) with highest values at day 3 that were sustained high at
day 14. Also NF-H, S110B, and Tau showed the trend of a peak at
FIGURE 2 | Elevated plus maze. Although there was a tendency of injured
animals to spend more time in open arms and less time in the closed arms of
the EPM, compared to control animals (A), this difference was not significant.
In addition, there were no significant differences in arm entries, episodes of
rearing or crossings (B). Data expressed as mean±SD (n=11 sham, n=12
injured).
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FIGURE 3 | Radial arm maze. Statistically significant differences
were detected in the number of errors in the working memory at
day 5 (A) and in the reference memory paradigm at day 3 post injury
(B). However as it can be seen in the graphs the numerical
difference is not vast and the sham group also show impairment in
reference memory. Data expressed as mean±SD (n=11 sham,
n= 12 injured) and significant differences are indicated by *p < 0.05.
No significant differences could be observed in the number of visits
in the bated arms (C) or all arms (D) between the injured and sham
group (d, days).
day 3. Our follow up analysis with multiple comparisons showed
a significant difference between sham and injured animals at all
time points except in NF-H at day 14. The result of the follow up
multiple comparisons for each biomarker is presented in Figure 4,
where significant changes are indicated by (∗).
HISTOLOGY
No macroscopic hematomas or contusions were observed. In order
to verify our previous finding of axonal injury in brain tissue in this
TBI model we used β-APP. Positive β-APP immunoreactivity (IR)
was found in the corpus callosum and at the border zone of the
gray-white matter of the corpus callosum and the hippocampus.
No β-APP-IR was found in the sham-exposed animals. These find-
ings were in accordance with our previous reports on β-APP-IR in
this TBI model (Davidsson and Risling, 2011).
DISCUSSION
In the present study we detected axonal injuries both by histolog-
ical examination in the expected regions (Davidsson and Risling,
2011) and by significant increases of serum biomarkers follow-
ing TBI. There were transient memory impairment and no other
behavioral deficits could be detected. No evident intracerebral
hemorrhages, contusions, or vascular lesions were found. This
indicates that the acceleration impact induced in these animals
produces a mTBI.
Memory deficits are the most common cognitive measure dis-
played in patients with minor or mild TBI (Bazarian et al., 1999;
King et al., 1999; Bazarian and Atabaki, 2001; Bazarian et al., 2006).
In the current study, we found transient deficits in working and
reference memory but no alterations in other behavioral parame-
ters measured. Using the same set of behavioral testing used in the
current study in a penetrating TBI model, no impairment of work-
ing memory could be found (Plantman et al., 2012). However, a
persistent increase of errors in reference memory was found in the
injured animals. Indicating that the mild TBI in the current study
do not produce permanent memory deficits while a more severe
type of TBI does. Persisted behavioral deficits following severe TBI
has previously been reported in other TBI models (Pierce et al.,
1998). Furthermore in the penetrating TBI, we found that none of
the animals could balance or move on the beam walk 3 days fol-
lowing injury. Although the number of animals that could move
on the beam walk increased at the last day of experiment (day
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Table 1 | Results of RPPM.
Marker Time Injured Sham
Tau (4.5±0.20) Day 1 5.66±0.09 5.02±0.09
Day 3 6.10±0.10 4.64±0.06
Day 14 5.72±0.08 4.84±0.09
MBP (5.0±0.02) Day 1 5.33±0.05 5.10±0.01
Day 3 5.73±0.11 5.18±0.02
Day 14 5.63±0.07 5.17±0.07
NF-H (5.2±0.07) Day 1 5.79±0.09 5.40±0.08
Day 3 5.98±0.11 5.35±0.04
Day 14 5.86±0.08 5.49±0.05
S100B (5.9±0.28) Day 1 6.75±0.16 6.01±0.04
Day 3 7.00±0.09 6.13±0.02
Day 14 6.61±0.16 6.21±0.12
The results for each biomarker are given as theY-intercept values obtained from
the RPPM analysis. The Y-intercept values are given in log10 hence the power
of each fold change is vast (n=3 for each group). The values of normal controls
(n=6) are given in bracket. All values are given as mean±SD.
7), they showed an increased latency to complete the test. In the
current study no balance or sensory motor deficits were found at
any time point following injury. Furthermore, the EPM showed
decreased activity and level of anxiety following injury, in contrast
to the current findings. In case the penetrating TBI can serve as a
positive control and a more severe type of TBI, the results obtained
in the present study show that our model produces mTBI. A cor-
relation between the TBI severity and behavioral deficit have been
reported in other animal TBI models (Yu et al., 2009). It should be
noted that the first behavioral tests were performed 3 days follow-
ing injury and there might have been more behavioral deficits in
the acute phase after TBI. However, we believe that using the sub-
acute phase rather than the acute phase, excludes possible effects
of anesthesia and surgical intervention as contributing factors to
behavioral impairment. This assumption is supported by the fact
that the sham animals also showed a tendency of impairment at
3 days.
Previous studies have reported similar results following mTBI
produced by central fluid percussion model. Using RAM Lyeth
et al. (1990) demonstrated working memory deficits in absence
FIGURE 4 | Serum biomarkers.Y -intercept values are percentage increase
of each biomarker in sham animals (black bars) and injured animals (white
bars) compared to normal controls (NC), given as mean±SD. The biomarker
Tau (A) showed the most pronounced increase following injury. The multiple
comparison showed a significant increase in Tau, S100B (B), MBP (C) at all
time points compared to sham animals indicated by (*). The NF-H (D) showed
significant increase in injured animals compared to sham at day 1 and 3 but
not at 14 days following injury.
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of cell death or axonal injury in the hippocampus. Using Morris
water maze in rats exposed to mild lateral fluid percussion (LFP)
injury a significant impairment in memory was observed without
any damaged to neurons in the hippocampus (Scheff et al., 1997).
This is in line with our current and previous finding that despite
the absence of structural changes in the hippocampus the animals
showed transient memory impairment. Using TUNEL and Fluoro-
Jade staining in present rotational TBI no evident cell death could
be detected (Manuscript in preparation). Moreover, microarray
analysis of the hippocampus in this TBI model showed low activ-
ity of genes related to apoptosis and cell death (Risling et al., 2011).
However compared to hippocampus of animals exposed to blast-
or penetrating TBI, this injury had the greatest impact on the hip-
pocampus, measured by number of responding genes. These genes
were found in functionally related groups such as cell development
and differentiation, inflammatory response, receptor activity, sig-
nal transduction, and response to stress. It is possible that many
of these genes are involved in recovery and regenerative processes
rather than cell death mediating and deleterious effects. These
issues will be the subjects of further investigation in our labora-
tory in addition to longer survival time for analysis of behavior
outcome.
In order to get an indication of whether restricted axonal
pathology can be assessed by serological biomarkers we analyzed
NF-H, Tau, S100B, and MBP by RPPM. NF-H is particularly
abundant in axons (Julien and Mushynski, 1998). Proteolysis of
neurofilaments following TBI is believed to play an important role
in axonal injury, leading to cytoskeleton disruption followed by
impaired transport and swelling. The peak of serum NF-H was
also found at day 3 post injury. Release of NF-H in serum has been
previously studied in TBI (Anderson et al., 2008), the phospho-
rylated form of NF-H was analyzed and increased significantly in
moderate and severe TBI but not in mTBI. Using RPPM for NF-H
analysis in a blast TBI model, showed that NF-H is correlated to
injury severity and that in the mild injury group it peaked 3 days
after injury (Gyorgy et al., 2011). The findings in the latter study
are in line with those of the present study and indicate that the
axonal injury could be detected in serum up to day 3 but not later
time points since no significant difference were found between
sham and injured animals at day 14. An additional marker that
may indicate axonal injury is Tau. In this study Tau showed the
most significant percentage increase. It is a microtubule associ-
ated protein in neurons, predominantly located in axons (Binder
et al., 1985). High serum levels of Tau following mTBI have been
reported both in patients (Bulut et al., 2006; Kavalci et al., 2007)
and in rats (Liliang et al., 2010) with conflicting results. It has
been suggested by some to enable the identification of high-risk
patients with mTBI (Bulut et al., 2006) while others conclude that
serum Tau has limited value in this context (Kavalci et al., 2007).
In the present study we detected increased serum Tau at all time
points following injury, with a peak at day 3. This indicates Tau
as a promising marker for mTBI. This trend was also observed in
NF-H, MBP, and S100B and peaks of these biomarkers 2–3 days
following injury have previously been reported. It has been shown
that rats exposed to TBI produced a second peak of serum NF after
2 days (Shaw et al., 2005).
Myelin basic protein is a structural protein in the myelin sheath
surrounding the axons. Myelin degradation can be expected to
occur secondary to axonal injury and has been shown in brain
tissue of patients with DAI (Ng et al., 1994). In animals exposed
to TBI an extensive degradation of MBP was detected within
hours following experimental TBI (Liu et al., 2006). In the present
study high levels of MBP was detected at day 1 but most interest-
ingly MBP peaked at day 3 and sustained high 14 days following
injury. This suggests that the late MBP increase in serum is due to
myelin degradation following axonal injury. This trend has also
been shown in TBI patients and interpreted as myelin degra-
dation following axonal injuries (Thomas et al., 1978; Berger
et al., 2005). In addition the same trend of serum MBP, ana-
lyzed by RPPM, was shown in pigs exposed to blast TBI (Gyorgy
et al., 2011). High levels of MBP were present 2 weeks following
injury.
S100B is the most investigated serum biomarker in TBI
(Donato, 1999). S100B has shown to correlate with TBI severity
and predict normal CT-findings in mTBI (Unden and Romner,
2010). In a previous study using the present TBI model, we have
shown an increase of serum S100B as early as 2–3 h following
trauma, measured by ELISA (Davidsson and Risling, 2011). In
this study using RPPM, we could confirm the release of S100B in
serum for up to 14 days following injury. The current communica-
tion and several previous studies indicate the usefulness of RPPM
as a screening tool for known biomarkers (Spurrier et al., 2008).
Obviously, as in the case of all immunoassays, there is a great
dependence on the specificities of antibodies used. This issue can
be solved by extensive screening of antibodies by Western blotting
and the use of open resources databases (Nishizuka et al., 2003). A
further limitation of RPPM currently is that the protein concen-
tration levels are relative and hence cannot be given in metric units.
This can make it difficult to obtain threshold values, however the
suspect biomarkers can be screened and then further investigated
with methods such as ELISA for generating values to be used in
the clinic.
The serum biomarkers indicated axonal injury as a result of
mTBI during this study which corresponds to current and previous
histological findings of axonal lesions by using β-APP (Davidsson
and Risling, 2011). The significance of axonal injury in mTBI has
been previously demonstrated in patients (Blumbergs et al., 1994,
1995).
In summary, the transient memory impairment in combina-
tion with the absence of other behavioral deficits in this model
indicates that the TBI produced corresponds to a mild type of
TBI. Furthermore, the main histological findings using this model
were axonal injuries. Interestingly, this could also be detected by
biomarkers in serum. This suggests that this model can be used
for further analysis of underlying pathology causing mTBI as well
as further investigation of possible biomarkers that can be used in
clinical settings as diagnostic and prognostic tools.
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